Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
283 GBX | -2.41% | -4.07% | 0.00% |
06-07 | Hutchmed (China) begins trial of menin inhibitor HMPL-506 | AN |
06-07 | Hutchmed Begins Phase 1 Trial of Potential Treatment for Acute Myeloid Leukemia | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
0.00% | 3.07B | |
+45.82% | 765B | |
+40.95% | 632B | |
-6.16% | 354B | |
+19.86% | 331B | |
+9.32% | 299B | |
+18.45% | 248B | |
+11.88% | 216B | |
-0.78% | 219B | |
+5.90% | 164B |
- Stock Market
- Equities
- HCM Stock
- News HUTCHMED (China) Limited
- Hutchmed Announces Retirement of Simon To as Chairman, Names Dan Eldar Successor